Meeting Coverage
ESC
European Society of Cardiology Congress
Latest ESC Meeting Coverage
Benefits seen in patients with and without a genetic diagnosis
Trial paints a fuller picture of risk-benefit in complex patient population
Afib, hypertension, and others get updates with simplifications
More conclusive evidence for benefits on Afib burden, QoL
First adequately powered randomized trial suggests larger vessel disease isn't the right fit
Bleeding reduced -- without risk of ischemic events -- versus dual antithrombotic in Korean trial
Randomized trial shows benefits beyond heart failure with low ejection fraction, but not survival
NOTION-3 trial informs care for those with severe AS and stable CAD
RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates
Randomized trial "highly encouraging" for making patients feel and function better
First randomized trial debunks common practice of tight control
Either choice is "acceptable" based on randomized study
And two aren't in the standard cardiovascular risk prediction tool
RNA silencer impresses with results in transthyretin amyloidosis cardiomyopathy
Latest Cardiology Meeting Coverage
-
TCT: Transcatheter Cardiovascular Therapeutics
October 2024
-
HFSA: Heart Failure Society of America
September 2024
-
ESC: European Society of Cardiology Congress
August 2024
-
TVT: Transcatheter Valve Therapy
June 2024